ClinVar Miner

Submissions for variant NM_001323289.2(CDKL5):c.2465G>A (p.Arg822His)

gnomAD frequency: 0.00004  dbSNP: rs376429571
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV003448302 SCV004176031 likely benign CDKL5 disorder 2023-02-20 reviewed by expert panel curation The p.Arg822His variant in CDKL5 is present in 3 XX and 1 XY individuals in gnomAD v3.1.2 (0.0076%) (not sufficient to meet BS1 criteria). Computational analysis prediction tools suggest that the p.Arg822His variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Arg822His variant is observed in at least 2 unaffected individuals (internal database-GeneDX) (BS2). In summary, the p.Arg822His variant in CDKL5 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP4).
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000420425 SCV000511256 uncertain significance not provided 2016-11-30 criteria provided, single submitter clinical testing Converted during submission to Uncertain significance.
Genetic Services Laboratory, University of Chicago RCV000503048 SCV000593966 uncertain significance not specified 2016-03-04 criteria provided, single submitter clinical testing
Invitae RCV001034449 SCV001197805 likely benign Developmental and epileptic encephalopathy, 2; Angelman syndrome-like 2023-10-06 criteria provided, single submitter clinical testing
GeneDx RCV000420425 SCV002567479 likely benign not provided 2021-05-07 criteria provided, single submitter clinical testing See Variant Classification Assertion Criteria.
Ambry Genetics RCV002446647 SCV002732332 uncertain significance Inborn genetic diseases 2019-07-30 criteria provided, single submitter clinical testing The p.R822H variant (also known as c.2465G>A), located in coding exon 16 of the CDKL5 gene, results from a G to A substitution at nucleotide position 2465. The arginine at codon 822 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003897838 SCV004708649 likely benign CDKL5-related condition 2023-08-02 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.